Send Message
Home News

company news about JN.1: The New COVID-19 Variant

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
JN.1: The New COVID-19 Variant
Latest company news about JN.1: The New COVID-19 Variant

JN.1 is a COVID-19 variant that has emerged as "another Omicron variant" and is believed to have descended from the BA.2.86 variant. JN.1 has been reported in several countries, including the U.S., Iceland, Portugal, Spain, the Netherlands, and its frequency is increasing in France. Currently, there is no available data suggesting that JN.1 causes different symptoms compared to previous COVID-19 variations.


The symptoms of COVID-19, as identified by the CDC, may include fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea.


To prevent the spread of JN.1 and other COVID-19 variants, the following precautions are important:


  • Wearing masks, particularly in indoor settings or areas with high transmission rates, can help reduce the risk of getting infected and prevent the spread of the virus.
  • Ensure high-risk individuals receive vaccine protection: It is crucial to prioritize high-risk individuals, such as the elderly or those with underlying health conditions, for vaccination. Vaccines have been shown to be effective in reducing the risk of severe illness and hospitalization.
  • Promptly provide antiviral medications: If high-risk individuals do become infected with JN.1 or other COVID-19 variants, it is important to promptly provide them with appropriate antiviral medications as recommended by healthcare professionals.


JN.1 and other COVID-19 variants are currently present and will continue to circulate, so it is essential to remain vigilant and take necessary measures to minimize the risk of illness.

Pub Time : 2023-12-18 09:06:39 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)